FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012608497> ?p ?o ?g. }

• W2012608497 endingPage "383" @default.
• W2012608497 startingPage "370" @default.
• W2012608497 abstract "Tacrolimus has proven to be superior to cyclosporine-Sandimmune with regard to the prevention of acute rejections, but data comparing tacrolimus with Neoral are scarce. A total of 128 consecutive renal transplant recipients was studied. The patients were treated with Neoral-based (n = 74) or tacrolimus-based (n = 54) immunosuppressive regimens. Survival analyses (Cox regression analysis) were performed on an intention-to-treat basis. Renal function and cardiovascular risk profile were analyzed by means of a repeated-measures analysis of variance (ANOVA) up to 12 months after transplantation. Immunological features were less favorable in the tacrolimus group. Two-year patient and graft survival were comparable. Acute-rejection-free survival was 82 % in the tacrolimus group versus 40 % in the Neoral group (P < 0.0001). The severity of the rejections (1997 Banff classification) was comparable (P = 0.43). Immunological graft loss (3.7 % vs. 12.2 %, P = 0.02) and conversion because of rejection (0 % vs. 28.4 %, P < 0.001) were less in the tacrolimus group. A higher proportion (68.5 % vs. 14.9 %, P < 0.001) was successfully put on monotherapy. Creatinine clearance, proteinuria, and fractional uric acid clearance were similar. In the tacrolimus group mean blood pressure was comparable, but patients needed less anti-hypertensive drugs (P < 0.001) and, even with fewer patients on lipid-lowering drugs, total cholesterol was lower (5.2 vs. 6.0 mmol/l, P = 0.003). Treatment for post-transplant diabetes mellitus was 18.5 % versus 10.8 % (P = 0.22). In both groups, antidiabetic medication could be withdrawn for most patients. This study indicates that tacrolimus is superior to cyclosporine-Neoral in preventing acute rejection with comparable patient and graft survival rates. Because of a lower need for treatment of hypertension and hypercholesterolemia, the cardiovascular risk profile is more favorable. A considerable proportion of patients can be successfully weaned off co-medication and treated with tacrolimus monotherapy." @default.
• W2012608497 created "2016-06-24" @default.
• W2012608497 creator A5020256518 @default.
• W2012608497 creator A5047871584 @default.
• W2012608497 creator A5063827633 @default.
• W2012608497 creator A5067963250 @default.
• W2012608497 creator A5071021604 @default.
• W2012608497 creator A5088577587 @default.
• W2012608497 date "2001-11-01" @default.
• W2012608497 modified "2023-09-26" @default.
• W2012608497 title "Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients" @default.
• W2012608497 cites W1550111394 @default.
• W2012608497 cites W1583559519 @default.
• W2012608497 cites W166739738 @default.
• W2012608497 cites W1873439693 @default.
• W2012608497 cites W1963899523 @default.
• W2012608497 cites W1966184087 @default.
• W2012608497 cites W1966423093 @default.
• W2012608497 cites W1982538695 @default.
• W2012608497 cites W1984906188 @default.
• W2012608497 cites W1994059773 @default.
• W2012608497 cites W1995791071 @default.
• W2012608497 cites W1998099663 @default.
• W2012608497 cites W2009236577 @default.
• W2012608497 cites W2015933357 @default.
• W2012608497 cites W2016247805 @default.
• W2012608497 cites W2021104069 @default.
• W2012608497 cites W2027371366 @default.
• W2012608497 cites W2031213157 @default.
• W2012608497 cites W2032842223 @default.
• W2012608497 cites W2035792755 @default.
• W2012608497 cites W2036955655 @default.
• W2012608497 cites W2043926592 @default.
• W2012608497 cites W2044600432 @default.
• W2012608497 cites W2048571115 @default.
• W2012608497 cites W2052445800 @default.
• W2012608497 cites W2064287642 @default.
• W2012608497 cites W2066925307 @default.
• W2012608497 cites W2070221679 @default.
• W2012608497 cites W2071690767 @default.
• W2012608497 cites W2072874441 @default.
• W2012608497 cites W2076597593 @default.
• W2012608497 cites W2078718522 @default.
• W2012608497 cites W2082014437 @default.
• W2012608497 cites W2084306201 @default.
• W2012608497 cites W2095379592 @default.
• W2012608497 cites W2099613288 @default.
• W2012608497 cites W2124518557 @default.
• W2012608497 cites W2126799263 @default.
• W2012608497 cites W2133753967 @default.
• W2012608497 cites W2157723948 @default.
• W2012608497 cites W2159262906 @default.
• W2012608497 cites W2160539239 @default.
• W2012608497 cites W2160917955 @default.
• W2012608497 cites W2166121680 @default.
• W2012608497 cites W2324876747 @default.
• W2012608497 cites W2326320134 @default.
• W2012608497 cites W2398464698 @default.
• W2012608497 cites W2408766650 @default.
• W2012608497 cites W24119347 @default.
• W2012608497 cites W2418680203 @default.
• W2012608497 cites W2434299180 @default.
• W2012608497 cites W2470247601 @default.
• W2012608497 cites W2472275816 @default.
• W2012608497 cites W2764387593 @default.
• W2012608497 cites W2099123520 @default.
• W2012608497 doi "https://doi.org/10.1007/s001470100002" @default.
• W2012608497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11793034" @default.
• W2012608497 hasPublicationYear "2001" @default.
• W2012608497 type Work @default.
• W2012608497 sameAs 2012608497 @default.
• W2012608497 citedByCount "19" @default.
• W2012608497 countsByYear W20126084972013 @default.
• W2012608497 countsByYear W20126084972020 @default.
• W2012608497 countsByYear W20126084972021 @default.
• W2012608497 crossrefType "journal-article" @default.
• W2012608497 hasAuthorship W2012608497A5020256518 @default.
• W2012608497 hasAuthorship W2012608497A5047871584 @default.
• W2012608497 hasAuthorship W2012608497A5063827633 @default.
• W2012608497 hasAuthorship W2012608497A5067963250 @default.
• W2012608497 hasAuthorship W2012608497A5071021604 @default.
• W2012608497 hasAuthorship W2012608497A5088577587 @default.
• W2012608497 hasConcept C126322002 @default.
• W2012608497 hasConcept C126894567 @default.
• W2012608497 hasConcept C159641895 @default.
• W2012608497 hasConcept C2779528694 @default.
• W2012608497 hasConcept C2779561371 @default.
• W2012608497 hasConcept C2780091579 @default.
• W2012608497 hasConcept C2780306776 @default.
• W2012608497 hasConcept C2909675724 @default.
• W2012608497 hasConcept C2911091166 @default.
• W2012608497 hasConcept C71924100 @default.
• W2012608497 hasConcept C90924648 @default.
• W2012608497 hasConceptScore W2012608497C126322002 @default.
• W2012608497 hasConceptScore W2012608497C126894567 @default.
• W2012608497 hasConceptScore W2012608497C159641895 @default.
• W2012608497 hasConceptScore W2012608497C2779528694 @default.
• W2012608497 hasConceptScore W2012608497C2779561371 @default.

• next